Express Pharma
Express Pharma
Browsing tag
Kesimpta
Multiple sclerosis market to generate sales of $29.8 bn by 2030: GlobalData
Read more
US FDA approves Novartis Kesimpta (ofatumumab) for relapsing forms of MS treatment
Read more